"Anaphylaxis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
| Descriptor ID |
D000707
|
| MeSH Number(s) |
C20.543.480.099
|
| Concept/Terms |
Anaphylaxis- Anaphylaxis
- Shock, Anaphylactic
- Anaphylactic Shock
- Anaphylactic Reaction
- Anaphylactic Reactions
- Reaction, Anaphylactic
- Reactions, Anaphylactic
|
Below are MeSH descriptors whose meaning is more general than "Anaphylaxis".
Below are MeSH descriptors whose meaning is more specific than "Anaphylaxis".
This graph shows the total number of publications written about "Anaphylaxis" by people in this website by year, and whether "Anaphylaxis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 2 | 2 | 4 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 3 | 0 | 3 |
| 2002 | 2 | 1 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 2 | 3 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 2 | 3 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 1 | 3 |
| 2018 | 8 | 2 | 10 |
| 2019 | 2 | 1 | 3 |
| 2020 | 5 | 0 | 5 |
| 2021 | 6 | 2 | 8 |
| 2022 | 3 | 0 | 3 |
| 2023 | 5 | 0 | 5 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anaphylaxis" by people in Profiles.
-
To the ER? Can Patients Treat Their Anaphylaxis at Home? Curr Allergy Asthma Rep. 2024 Nov; 24(11):623-629.
-
High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy. Int Immunopharmacol. 2024 Mar 30; 130:111767.
-
Can we identify patients at risk of severe reactions to food? Expert Rev Clin Immunol. 2023 Jul-Dec; 19(12):1427-1430.
-
Insights from a single center registry of infant and toddler anaphylaxis: Food and fire ants. J Allergy Clin Immunol Pract. 2024 01; 12(1):223-225.
-
Epinephrine autoinjectors: How many is too many? Ann Allergy Asthma Immunol. 2023 08; 131(2):137-138.
-
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A?GRADE assessment and international consensus approach. J Allergy Clin Immunol. 2023 08; 152(2):309-325.
-
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Engl J Med. 2023 May 11; 388(19):1755-1766.
-
Anaphylaxis during Peanut Oral Immunotherapy: Looking beyond dose escalation. Pediatr Allergy Immunol. 2022 12; 33(12):e13888.
-
Management of Anaphylaxis During Peanut Oral Immunotherapy. Curr Allergy Asthma Rep. 2023 01; 23(1):21-27.
-
Anaphylaxis after COVID-19 vaccination: A registry-based study. J Allergy Clin Immunol Pract. 2022 11; 10(11):3020-3023.